Big Pharma Increasingly Pursues Long-Term Deal Investment
By Heather Cartwright
PharmaDeals Corp-METRx: Vol 2012 Issue 1 (Table of Contents)
Published: 16 Jan-2012
DOI: 10.3833/pdcmx.v2012.i1.1670 ISSN: 2047-7007
Section: Quarterly Review
Fulltext:
Abstract
Roche, Pfizer and GlaxoSmithKline (GSK) have begun 2012 as they ended 2011 as the top 3 companies, respectively, in the PharmaDeals Corp-METRx Deal Activity League Table...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018